ABSTRACT. It has been suggested that the liver is not the main source of angiotensinogen during fetal life in rats, but that the kidney is an important site of fetal angiotensinogen synthesis. In an effort to determine if this phenomenon is specific to the rat or applicable to other species, we compared the ontogenic changes in hepatic and renal angiotensinogen mRNA expression in fetal (60, 90, 118, and 138 d of gestation, term being 145 d), newborn (7 d postnatal), and adult sheep. Total RNA was extracted, subjected to Northern blotting and hybridized using a fulllength rat radiolabeled antisense RNA. Angiotensinogen mRNA sequences were detected in all fetal liver samples and appeared to increase 3-fold from 60 to 138 d gestation and then to decrease after birth. In contrast, angiotensiogen mRNA could not be detected in renal cortical tissue of 118 or 138 d fetuses, or newborn or adult sheep. We conclude that, unlike in the rat, liver angiotensinogen gene expression is detectable during the 2nd trimester of gestation in sheep and is developmentally regulated. Furthermore, in contrast to the fetal rat, angiotensinogen mRNA sequences were undetectable in fetal sheep kidney. (Pediatr Res 28: 183-185,1990) Abbreviations SSPE, 0.18 M NaCI, 10 mM NaP04 pH 7.7,l mM EDTA The existence of a functional renin-angiotensin system during fetal life has been documented (1) and developmental aspects of this system have been recently reviewed (2). It has been shown that fetal plasma levels of renin, angiotensinogen, angiotensin I, and angiotensin I1 are elevated when compared with adult values (3), and that the kidney is the primary source of circulating renin in near-term fetus (4), as it is in the adult.
The existence of a functional renin-angiotensin system during fetal life has been documented (1) and developmental aspects of this system have been recently reviewed (2) . It has been shown that fetal plasma levels of renin, angiotensinogen, angiotensin I, and angiotensin I1 are elevated when compared with adult values (3) , and that the kidney is the primary source of circulating renin in near-term fetus (4), as it is in the adult.
It has also been demonstrated that the primary source of angiotensinogen synthesis in the adult is the liver (5) . On the other hand, recent studies by Gomez et al. (6) suggest that the liver may not be the main source of angiotensinogen during fetal life, but that the kidney and possibly brown fat and brain are also important sites of angiotensinogen synthesis in the fetal rat. Interestingly, they have also observed that the expression of liver angiotensinogen increases rapidly in the first 24 h after birth in the rat, suggesting that the developmental regulation of angiotensinogen is tissue-specific.
In an effort to determine if this phenomenon is specific to the rat or applicable to other species, we compared the ontogenic Received January 18, 1990 ; accepted April 16, 1990 changes in hepatic and renal angiotensinogen gene expression during the last trimester of gestation in fetal sheep. We demonstrated that, unlike in the rat, hepatic angiotensinogen gene expression in sheep is detectable early during the last trimester of gestation and increases as the fetus approaches birth. Furthermore, in contrast to the rat, renal angiotensinogen mRNA sequences were undetectable in fetal sheep.
MATERIALS AND METHODS
Animals. Pregnant mixed-breed Dorset-Suffolk ewes and newborn lambs (7 d postnatal) were obtained from a local source; the gestational age was known based on the induced-ovulation technique (7) . Pregnant ewes were anesthetized with a mixture of 1.0-1.5% halothane, 33% oxygen, and 66% nitrous oxide given by an endotracheal tube (8) . The uterus was exteriorized to gain access to fetuses. Liver and kidney cortex samples were obtained from fetuses at 60, 90, 118, and 138 d gestation, term being 145 d. Newborn lambs were similarly anesthetized before tissue harvest. All procedures were approved by the University of Iowa Animal Care and Use Committee.
RNA isolation. RNA was isolated using a minor modification of the guanidinium isothiocyanate-CsC1 method of Chirgwin et al. (9) . With our modification, 0.5 g of fresh tissue was homogenized in 5 M guanidinium isothiocyanate in a buffer consisting of 30 mM Na acetate buffer, pH 5.2, 10 mM EDTA, pH 5.0, 0.2% sarcosyl, and 5.0% 2-mercaptoethanol. CsCl was added to the tissue homogenate at a final concentration of 0.4 g/mL, and this mixture was layered over a cushion of 5.7 M CsC1, 30 mM Na acetate buffer, pH 5.2, 10 mM EDTA. The RNA was pelleted by centrifugation at 35 000 rpm for 16 h at 20°C. The RNA pellet was purified by extraction with chloroform:butanol and ethanol precipitated in the presence of 0.3 M Na acetate buffer, pH 5.2. RNA was quantified spectrophotometrically by absorbance at 260 nM. RNA samples were stored as an ethanol precipitate at -70°C until further analysis.
Preparation of probes. A clone containing full-length rat angiotensinogen cDNA (pRang 6) (10) was obtained from K. R. Lynch. This cDNA, when linearized with EcoRI, yields the antisense mRNA upon transcription from the T7 promoter. A 2.0-kb fragment of P-actin cDNA (1 1) that had been subcloned into pSP18 (Promega, Madison, WI) as described (12) was obtained from P. Rubenstein. After linearization of this plasmid with EcoRI, transcription from the SP6 promoter yields the antisense mRNA. 32P-labeled antisense mRNA were transcribed according to the method of Melton et al. (1 3) using ~u-~~P-uridine triphosphate (Amersham Corp., Arlington Heights, IL).
Northern blot hybridization. Aliquots of 5 or 10 pg of RNA as measured by absorbance at 260 nm were fractionated by 1% agarose-formaldehyde gel electrophoresis (14) . After electrophoresis, RNA was transferred to Nytran filters, 0.45 Fm (Schleicher and Schuell Inc., Keene, NH). The filters were prehybridized for 1 h at 60°C in a solution of 50% deionized formamide, 5 x SSPE, 5 x Denhardt's reagent, 1.0% SDS and 200 pg/mL denatured fractionated salmon sperm DNA. Hybridization of 83 filters with either 32P-labeled angiotensinogen or p-actin mRNA was done with fresh prehybridization buffer solution containing 1 x lo6 cpm/mL of the appropriate radio-labeled probe. The hybridization reaction was carried out at 60°C 12-18 h.
Filters were washed according to manufacturer's specifications. Briefly, this included three low-stringency washes (1 x SSPE, 1.0% SDS) at 65°C and a high stringency wash (0.1 x SSPE, 1.0% SDS) at 60°C followed by treatment with ribonuclease A (10 pg/mL in 2 x SSPE) at 37°C for 15 min. The washed filters were exposed to Kodak XAR film at -70°C.
The autoradiographs from Northern blots were quantitated using a Soft Laser scanning densitometer, model SLR-2D10 (Biomed Instruments, Inc., Fullerton, CA). Results of separate Northern blots were normalized by calculating all bands to a single 138 d fetus sample, which was run on each Northern blot. This band was considered 100% expression. All data were subsequently expressed as a percent of this sample. Individual liver samples were analyzed in duplicate or triplicate and the mean value for each analysis was then used to calculate the grand mean for livers within each age group. Age-related changes in angiotensinogen mRNA expression were analyzed by one-way analysis of variance (1 5).
RESULTS
Changes in the level of angiotensinogen mRNA in the liver of fetal sheep are shown in Figure 1 . Using Northern blot hybridization, we observed a progressive increase in hepatic angiotensinogen mRNA during gestation. Moreover, the size of the angiotensinogen message did not appear to change during gestation. Among the fetal and newborn sheep, it appeared that the highest level of liver angiotensinogen mRNA was expressed in the nearterm fetuses. In contrast, duplicate samples of RNA analyzed for p-actin mRNA expression (Fig. 2) showed no changes with gestation. Quantitation of angiotensinogen and p-actin mRNA is summarized in Table 1 . These results, expressed as percent of angiotensinogen mRNA present in 138-d fetuses, show that angiotensinogen mRNA increases about 3-fold from 60 to 138 d gestation, whereas there was no significant change in p-actin mRNA. This suggests that the developmental changes seen in
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In an effort to investigate the possibility that other tissues may also be important sources of angiotensinogen during fetal life, we compared angiotensinogen mRNA samples from fetal and newborn liver and kidney. Northern blot analysis of liver and kidney RNA from fetal sheep (1 18 and 138 d gestational age) 1 and newborn lamb are shown in Figure 3 . We were unable to detect angiotensinogen mRNA sequences in any of the kidney RNA samples at the three ages studied. Even with prolonged exposure to film (7 d, data not shown), no hybridized material was apparent in the kidney samples.
Additionally, we also determined if angiotensinogen mRNA ' is found in kidney of mature sheep. Total cellular RNA was / isolated from kidney cortex and medulla of an adult male and probed for angiotensinogen. Northern blot analysis (Fig. 4) shows that angiotensinogen sequences were undetectable in both kidney cortex and medulla.
DISCUSSION
Through Northern hybridization, we have shown that angiotensinogen mRNA sequences are present in fetal sheep liver at least by 60 d of gestation. The amount of angiotensinogen mRNA per unit of total RNA increases in the fetal liver with increasing gestational age. After birth, the amount of angiotensinogen message appears to decrease slightly. We have not determined if increases in liver angiotensinogen during gestation parallel increases in circulating angiotensinogen and plasma angiotensin I1 concentration.
Changes in angiotensinogen gene expression in liver and other tissue in response to a variety of physiologic and hormonal stimuli have been studied in adult animals (16) (17) (18) (19) (20) . However, there is presently no data available regarding factors regulating angiotensinogen gene expression during fetal life. Inasmuch as angiotensinogen mRNA expression undergoes a maturational process, it is likely that gene regulatory mechanisms also undergo maturation.
The results of our study suggest that the ontogeny of angiotensinogen may differ between species. The development of angiotensinogen mRNA in the sheep appears to be quite different from development in the rat. This may be due to maturational differences between the sheep and rat at the time of birth, inasmuch as the newborn lamb is much more mature at birth than is the rat. Liver angiotensinogen mRNA sequences appear in the neonatal rat about 24 h after birth (6) . This may be similar to the increase in angiotensinogen mRNA that we have seen between 1 18 and 138 d gestation in fetal sheep.
We were unable to detect the presence of angiotensinogen mRNA in either fetal, newborn, or mature sheep kidney. This was unexpected, inasmuch as angiotensinogen mRNA sequences have been demonstrated in the kidney of adult rats (2 1-24). The relative quantity of renal angiotensinogen mRNA to liver angiotensinogen mRNA ranges from 5 (25) to approximately 50% (26) per unit of total RNA in rat. Gomez et al. (6) reported the presence of angiotensinogen mRNA in total RNA extracts from fetal rat kidney; however, angiotensinogen mRNA was detectable at low levels in fetal rat liver only after poly A+ selection of liver RNA. This suggests a relatively high abundance of angiotensinogen mRNA in fetal rat kidney compared with fetal rat liver. Our current methodology allows us to measure 100-fold differences in sequence abundance (27) ; therefore, if angiotensinogen mRNA is present in the sheep kidney, it is less than 1% the amount of angiotensinogen mRNA found in sheep liver.
